A Popular Decongestant Doesn’t Work. The FDA Is Finally Doing Something About It

In a long-sought move, the US Food and Drug Administration on Thursday formally began the process of abandoning oral doses of a common over-the-counter decongestant that the agency concluded last year is not effective at relieving stuffy noses.

Specifically, the FDA issued a proposed order to remove oral phenylephrine from the list of drugs that drugmakers can include in over-the-counter products—also known as the OTC monograph. Once removed, drugmakers will no longer be able to include phenylephrine in products for the temporary relief of nasal congestion.

“It is the FDA’s role to ensure that drugs are safe and effective,” Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research,

→ Continue reading at Wired - Science

More from author

Related posts

Advertisment

Latest posts

An All-in-One PDF Solution for Business Pros Is Just $79.99 for Life

Disclosure: Our goal is to feature products and services that we think you'll find interesting and useful. If you purchase them, Entrepreneur may...

Entrepreneurial Success Comes Down to Having the Right Mindset — Here’s How to Make Sure You Do

Opinions expressed by Entrepreneur contributors are their own. Mastering your mindset can change not just your business, but your life — I...

Bitcoin hits $80,000. Why Trump is boosting crypto | CNN Business

CNN  —  Bitcoin on Sunday hit a new record above $80,000. The world’s largest cryptocurrency surged in the...